Innorules Co.,Ltd (KOSDAQ:296640)

Ligand Pharmaceuticals Ratios and Metrics

Market cap in millions KRW. Fiscal year is January - December.

Fiscal Year	Current	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Aug 6, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Market Capitalization	33,212	31,443	36,624	39,264	-	-
Market Cap Growth	-22.61%	-14.15%	-6.72%	-	-	-
Enterprise Value	15,808	14,465	21,741	17,273	-	-
Last Close Price	6570.00	6220.00	6877.67	9154.13	-	-
PE Ratio	10.58	10.24	1052.96	18.27	-	-
PS Ratio	1.35	1.33	2.36	2.42	-	-
PB Ratio	1.03	0.96	1.22	1.25	-	-
P/TBV Ratio	1.04	0.97	1.23	1.26	-	-
P/FCF Ratio	14.10	7.98	109.51	12.27	-	-
P/OCF Ratio	13.16	7.67	100.12	11.49	-	-
EV/Sales Ratio	0.64	0.61	1.40	1.06	-	-
EV/EBITDA Ratio	5.38	5.17	-	11.14	-	-
EV/EBIT Ratio	6.48	6.21	-	13.41	-	-
EV/FCF Ratio	6.71	3.67	65.00	5.40	-	-
Debt / Equity Ratio	0.22	0.21	0.02	0.01	0.12	0.51
Debt / EBITDA Ratio	2.39	2.46	-	0.15	0.48	1.91
Debt / FCF Ratio	2.98	1.75	2.03	0.07	0.81	3.56
Asset Turnover	0.61	0.58	0.45	0.62	1.06	0.72
Quick Ratio	2.18	2.18	6.59	6.81	2.39	1.39
Current Ratio	2.66	2.59	7.32	7.75	2.98	1.48
Return on Equity (ROE)	10.23%	9.77%	0.11%	9.67%	27.79%	25.75%
Return on Assets (ROA)	3.75%	3.58%	-2.24%	3.07%	12.51%	5.15%
Return on Capital (ROIC)	4.35%	4.13%	-2.48%	3.48%	15.10%	6.30%
Return on Capital Employed (ROCE)	7.40%	6.90%	-	4.00%	22.40%	16.50%
Earnings Yield	9.62%	9.77%	0.10%	5.47%	-	-
FCF Yield	7.09%	12.54%	0.91%	8.15%	-	-
Dividend Yield	3.79%	4.02%	-	-	-	-
Payout Ratio	9.53%	9.91%	1626.09%	4.36%	2.71%	-
Buyback Yield / Dilution	-2.98%	1.51%	-18.95%	-23.95%	-13.20%	-7.97%
Total Shareholder Return	0.87%	5.53%	-18.95%	-23.95%	-13.20%	-7.97%

Source: S&P Global Market Intelligence. Standard template. Financial Sources.